Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17228128 | 0.77 | L3MBTL1 (0.69) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL13309440 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL18042083 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL26788442 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL26788445 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL17617917 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL18779641 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL25674912 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL16491834 | 0.75 | L3MBTL1 (0.67) | L3MBTL1KDM4EATMHDAC4KMT2A | |
| SCHEMBL16410042 | 0.75 | L3MBTL1 (0.72) | L3MBTL1KDM4EATMHDAC4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180226580-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-08-09 | — | — | US | disclosed |
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | UDC IRELAND LTD (IE) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | SLC43A1, SLC6A19, AOC3 | L3MBTL1 871/4885KDM4E 3013/4885ATM 4294/4885 |
| US-20180226580-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SLCO4C1, SLCO2A1, SLCO2B1 | L3MBTL1 1634/4885KDM4E 3981/4885ATM 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.